Parkinsonism & Related Disorders

205 ta ish

Jurnal · ISSN 1353-8020

1. Cognitive disorders in Parkinsonism

   Sarvinoz Karakhonova, G.T. Ishanhodjaeva

   MaqolaNeurobiology of Language and BilingualismParkinsonism & Related Disorders20152 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.505891

2. Hormonal pathogenetic effects and vascular-immunological aspects in secondary vascular parkinsonism

   D. Akramova, G. Rakhimbaeva

   MaqolaNuclear Receptors and SignalingParkinsonism & Related Disorders20181 iqtibos

   ABIABI:AkademIndex/openalex/2018.article.000489

3. The influence of robotics and modern technologies to assist individuals with Parkinson's disease

   A. Kim, L. Alimbekova

   MaqolaNeurological disorders and treatmentsParkinsonism & Related Disorders20241 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.468165

4. The importance of Ishihara Testing in early diagnosing of Parkinson disease

   S. Mirdedaev

   MaqolaParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000092

5. Neuroophthalmic disorders in children with cerebral palsy

   I. K. Abdukadirova, Yokutxon Madjidova

   MaqolaOphthalmology and Eye DisordersParkinsonism & Related Disorders20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000153

6. Autonomic disorders in Parkinson Disease

   Jasur Toshev, Nodir Nurmetov, Oybek Kurbanov +1

   MaqolaHeart Rate Variability and Autonomic ControlParkinsonism & Related Disorders20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000295

7. Polymorphisms of genes of oxidative stress and glutamate excitotoxicity in patients with tardive dyskinesia in schizophrenia

   Nodir Nurmetov, Oybek Kurbanov, Zarifboy Ibodullaev +1

   MaqolaTryptophan and brain disordersParkinsonism & Related Disorders20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000398

8. Pathogenetic mechanisms in epileptic myoclonic hyperkinesia

   Oybek Kurbanov, Nodir Nurmetov, Zarifboy Ibodullaev +1

   MaqolaGlycogen Storage Diseases and MyoclonusParkinsonism & Related Disorders20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000400

9. Parkinson's disease with congenital porencephalia

   Mukhlisa Khanova, N. Tolibova, Oybek Turgunkhujaev +1

   MaqolaNeurological disorders and treatmentsParkinsonism & Related Disorders20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000401

10. The effectiveness of amantadine and dopamine in the treatment of Guillain-Barre syndrome

    Marat Tadjenov, Rustam Sadikov, Y. Musaeva +1

    MaqolaPeripheral Neuropathies and DisordersParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000412

11. EEG features of dyskinesias, complicated by levodopa therapy in patients with Parkinson's disease.

    Ulugbek Askhonov, Bahtiyar Gafurov, Gulomqodir Ashanov

    MaqolaAttention Deficit Hyperactivity DisorderParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000453

12. Dopaminergic medicines are drugs of choice for medicament-resistant facial nerve neuropathy

    A. AZIMOV, Rustam Sadykov, Shuxrat Dadajonov +2

    MaqolaPeripheral Neuropathies and DisordersParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000456

13. Changes in serum level of interferon-gamma, alpha tumor necrosis factor and autoantibodies in Parkinson's disease

    Elvina Giyazitdinova, Gulnora Rakhimbayeva, Y. Musayeva +1

    MaqolaT-cell and Retrovirus StudiesParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000549

14. Level of S100B protein in blood plasma depends on the form of Parkinson's disease

    Mirzo Juraev, Rustambek Matmurodov, K. Khalimova

    MaqolaS100 Proteins and AnnexinsParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000553

15. Quality of life in patients with Parkinson's Disease in Uzbekistan

    N. Tolibova, Mukhlisa Khanova, Oybek Turgunkhujaev

    MaqolaSocial and Behavioral StudiesParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000557

16. Blood lipid parameters in patients with Parkinson's disease

    Elvina Giyazitdinova, Bakhrom Muinjonov, Gulnora Rakhimbayeva +1

    MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000558

17. Experimental model of extrapyramidal disorders caused by reserpine

    D. Tursunov

    MaqolaCardiovascular Syncope and Autonomic DisordersParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000563

18. Hyposmia in progressive supranuclear palsy

    Bakhrom Muinjonov, Elvina Giyazitdinova

    MaqolaOlfactory and Sensory Function StudiesParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000582

19. The mutation causing the motor and behavioral disorders in white mice

    Oybek Turgunkhujaev, Rustambek Matmurodov, N. Tolibova +2

    MaqolaGenetics and Neurodevelopmental DisordersParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000609

20. Prevalence of depression and dementia in Parkinson's disease

    F. Yunusov, G. Rakhimbaeva

    MaqolaParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000615

21. Analysis of the effectiveness of CEA and evaluation of factors affecting its long-term results

    Makhsudjan Ataniyazov, G. Rakhimbaeva

    MaqolaAdvanced Power Generation TechnologiesParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000616

22. Relationship S100 protein levels in blood plasma with a frequency of occurrence of cardiovascular complications in Parkinson's disease

    Mirzo Juraev, Rustambek Matmurodov, K. Khalimova

    MaqolaS100 Proteins and AnnexinsParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000617

23. Use of the drug choline alfostserat (Gliatilin) in combined treatment of vascular parkinsonism

    Oybek Kurbanov, Nodir Nurmetov, Zarifboy Ibodullaev +1

    MaqolaNeurological Disorders and TreatmentsParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000618

24. Cases of negative effect of chronic whole-body vibration on the dynamics of the flow and the quality of life in patients with Parkinson's disease

    Oybek Turgunkhujaev, N. Tolibova, Mukhlisa Khanova +2

    MaqolaEffects of Vibration on HealthParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000619

25. Treatment and diagnosis with the use of neuropsychological scale in patients with subcortical parkinsonian dementia

    Nodirjon Sokhibnazarov, Fakhmiddin Muratov

    MaqolaNeurological and metabolic disordersParkinsonism & Related Disorders20150 iqtibos

    ABIABI:AkademIndex/openalex/2015.article.000620